View Document Preview and Link Document Date: 2014-09-02 09:27:20 Open Document File Size: 116,80 KB Share Result on Facebook
City Horsham / Chattanooga / Sellersville / Wilmington / Kenilworth / Tampa / Somerset / Bridgewater / / Company MEDA / Bausch & Lomb Inc. / GlaxoSmithKline / Sunovion Pharmaceuticals / Sanofi-Aventis Pharmaceutical Inc. / AstraZeneca LP / Teva / Schering Corporation / Schering-Plough / Chattem Inc. / Sepracor Inc / / Facility American College of Allergy / M arch / / IndustryTerm combination product / / MedicalCondition nasal polyps / perennial allergic rhinitis / rhinitis / nasal congestion / Allergy / runny nose / allergic rhinitis / seasonal allergic rhinitis / hay fever / Asthma / / Organization American Academy of Allergy / Joint Task Force on Practice Parameters / Joint Council of Allergy / Asthma / and Immunology / the American College / American Academy of Allergy / Asthma / and Immunology / Joint Council of Allergy / / Person Qnasl / / / Product fluticasone propionate / Nasacort AQ / Nasonex / Omnaris / flunisolide / triamcinolone / Flonase / Triamcinolone acetonide / Veramyst / Nasacort / Rhinocort / Beconase AQ / / ProvinceOrState New Jersey / / SocialTag 
STEP THERAPY POLICY Nasal Steroids Preferred Step Therapy Program To Initiate a Coverage Review, Call[removed]DRUGS AFFECTED: Beconase AQ® (beclomethasone nasal spray – GlaxoSmithKline)